Volume 17, Issue 11, Pages (November 2009)

Slides:



Advertisements
Similar presentations
Volume 70, Issue 1, Pages (July 2006)
Advertisements

Volume 9, Issue 5, Pages (November 2017)
Hypoxia reduces the inhibitory effect of IL-1β on chondrogenic differentiation of FCS- free expanded MSC  T. Felka, R. Schäfer, B. Schewe, K. Benz, W.K.
Hypoxia reduces the inhibitory effect of IL-1β on chondrogenic differentiation of FCS- free expanded MSC  T. Felka, R. Schäfer, B. Schewe, K. Benz, W.K.
Volume 4, Issue 3, Pages (March 2009)
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Volume 18, Issue 2, Pages (August 2013)
Human articular chondrocytes with higher aldehyde dehydrogenase activity have stronger expression of COL2A1 and SOX9  A. Unguryte, E. Bernotiene, E. Bagdonas,
Volume 132, Issue 2, Pages (February 2007)
Tumorigenic Cells Are Common in Mouse MPNSTs but Their Frequency Depends upon Tumor Genotype and Assay Conditions  Johanna Buchstaller, Paul E. McKeever,
Volume 9, Issue 4, Pages (April 2004)
VEGF Gene Delivery to Muscle
Blood-derived smooth muscle cells as a target for gene delivery
Mesenchymal Stem Cells Arrest Intervertebral Disc Degeneration Through Chondrocytic Differentiation and Stimulation of Endogenous Cells  Fan Yang, Victor.
Changfa Guo, MD, Husnain Kh. Haider, PhD, Winston S. N
Intranigral Transplantation of Epigenetically Induced BDNF-Secreting Human Mesenchymal Stem Cells: Implications for Cell-Based Therapies in Parkinson's.
Volume 23, Issue 3, Pages (September 2012)
Biological Progression from Adult Bone Marrow to Mononucleate Muscle Stem Cell to Multinucleate Muscle Fiber in Response to Injury  Mark A. LaBarge, Helen.
Volume 4, Issue 3, Pages (March 2009)
Volume 18, Issue 10, Pages (October 2010)
Volume 132, Issue 7, Pages (June 2007)
Thiazolidinediones Regulate Adipose Lineage Dynamics
Side population cells contribute to the genesis of human endometrium
Mathieu Blais, Myriam Grenier, François Berthod 
Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice  Keiichi Fukuda,
Volume 19, Issue 13, Pages (June 2017)
Molecular Analysis of Stem Cells and Their Descendants during Cell Turnover and Regeneration in the Planarian Schmidtea mediterranea  George T. Eisenhoffer,
Xiaoyin Xu, Zhong Yang, Qiang Liu, Yaming Wang  Molecular Therapy 
Overexpressing Centriole-Replication Proteins In Vivo Induces Centriole Overduplication and De Novo Formation  Nina Peel, Naomi R. Stevens, Renata Basto,
Volume 20, Issue 5, Pages (May 2012)
Volume 21, Issue 5, Pages (May 2013)
Volume 134, Issue 3, Pages (March 2008)
Volume 13, Issue 5, Pages (November 2013)
Volume 37, Issue 5, Pages (November 2012)
Volume 20, Issue 1, Pages (January 2012)
Volume 10, Issue 2, Pages (February 2018)
Volume 18, Issue 12, Pages (December 2010)
Volume 10, Issue 5, Pages (May 2012)
Volume 70, Issue 1, Pages (July 2006)
Alexandra Charruyer, Lauren R. Strachan, Lili Yue, Alexandra S
Volume 28, Issue 6, Pages (June 2008)
Valerie Horsley, Katie M Jansen, Stephen T Mills, Grace K Pavlath  Cell 
Volume 17, Issue 10, Pages (October 2009)
Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2.
Volume 10, Issue 5, Pages (May 2012)
Volume 2, Issue 1, Pages (January 2014)
Epithelial Cells in the Hair Follicle Bulge do not Contribute to Epidermal Regeneration after Glucocorticoid-Induced Cutaneous Atrophy  Dmitry V. Chebotaev,
Volume 12, Issue 6, Pages (December 2005)
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Volume 7, Issue 2, Pages (August 2016)
Volume 10, Issue 5, Pages (May 2012)
Codependent Activators Direct Myoblast-Specific MyoD Transcription
Muscle Satellite Cells Are Primed for Myogenesis but Maintain Quiescence with Sequestration of Myf5 mRNA Targeted by microRNA-31 in mRNP Granules  Colin G.
FOXP3+CD25− Tumor Cells with Regulatory Function in Sézary Syndrome
Volume 17, Issue 6, Pages (June 2009)
Volume 10, Issue 3, Pages (March 2018)
Common Developmental Pathway for Primitive Erythrocytes and Multipotent Hematopoietic Progenitors in Early Mouse Development  Toshiyuki Yamane, Aya Washino,
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Volume 21, Issue 3, Pages (March 2013)
Volume 26, Issue 2, Pages (February 2018)
Volume 2, Issue 3, Pages (March 2014)
Volume 6, Issue 2, Pages (February 2010)
Cellular Heterogeneity in the Mouse Esophagus Implicates the Presence of a Nonquiescent Epithelial Stem Cell Population  Aaron D. DeWard, Julie Cramer,
Volume 11, Pages (January 2019)
Volume 10, Issue 11, Pages (March 2015)
Volume 20, Issue 1, Pages (January 2012)
Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture  Yi Arial Zeng, Roel Nusse  Cell Stem Cell 
Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages  Jih-Shiuan Wang, MDa,b, Dominique Shum-Tim, MDa, Jacques.
Volume 15, Issue 9, Pages (September 2007)
Volume 15, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 17, Issue 11, Pages 1948-1958 (November 2009) Aldehyde Dehydrogenase Activity Identifies a Population of Human Skeletal Muscle Cells With High Myogenic Capacities  Karine Vauchez, Jean-Pierre Marolleau, Michel Schmid, Patricia Khattar, Alain Chapel, Cyril Catelain, Séverine Lecourt, Jérôme Larghéro, Marc Fiszman, Jean-Thomas Vilquin  Molecular Therapy  Volume 17, Issue 11, Pages 1948-1958 (November 2009) DOI: 10.1038/mt.2009.204 Copyright © 2009 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Immunohistological and flow cytometric characterization of ALDH+ cells in human skeletal muscle. (a) Immunohistofluorescence localization. An aldehyde dehydrogenase-positive (ALDH1+) cell (green, nucleus in blue) located outside muscle fibers delineated by laminin labeling (red, arrow heads) is in an endomysial position (merge, arrow). Bar = 10 µm. (b) Representative flow cytometric analysis of ALDH activity. Baseline fluorescence established in the presence of Aldefluor substrate and the inhibitor diethylaminobenzaldehyde. Gate 1 (G1) was defined to exclude debris (first panel). Based on G1, ALDHbr cells presented a shift of fluorescence defining the population in Gate 2 (G2) (second panel). Based on G2, SMALD+/CD34+ (G3) and SMALD+/CD34− (G4) were clearly discriminated by the level of allophycocyanin-conjugated CD34 labeling (third and fourth panels). (c) Illustrative dot plot phenotypic characterizations of SMALD sub-populations based on G2. Percentages relate to the total number of cells in G1. SMALD, skeletal muscle aldehyde dehydrogenase. Molecular Therapy 2009 17, 1948-1958DOI: (10.1038/mt.2009.204) Copyright © 2009 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Cell sorting and phenotypic analysis in vitro. (a) Flow cytometric analysis, gating, and sorting of dissociated muscle sub-populations. Cells were labeled for aldehyde dehydrogenase (ALDH) activity and CD34 expression. The shift of fluorescence defined the population in G1 (left panel) presenting high ALDH activity. The following gates defined the sub-populations on the basis of ALDH activity and allophycocyanin-conjugated CD34 labeling. G2: SMALD+/CD34+, G3: SMALD+/CD34−, G4: SMALD−/CD34+, and G5: SMALD−/CD34− cells (right panel). G2 and G3 were first determined on G1. (b) Immunocytofluorecence analysis of SMALD+/CD34− and SMALD+/CD34+. SMALD+ cells were labeled for ALDH activity (green) and extracellular markers (PE-conjugated, red) 18 hour (D0) and 6 days (D6) after plating. Nuclei were stained by DAPI (blue). SMALD+/CD34−: some cells only expressed CD44 on D0, whereas numerous cells expressed CD44, CD56, and CD146 on D6. SMALD+/CD34+: the cells only expressed CD34 on D0, whereas on D6 numerous cells expressed CD15 or CD44, but not CD34. Controls were obtained on D0 and D6 by omission of the primary antibodies. Bar = 10 µm. SMALD, skeletal muscle aldehyde dehydrogenase. Molecular Therapy 2009 17, 1948-1958DOI: (10.1038/mt.2009.204) Copyright © 2009 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 In vitro analysis of SMALD+/CD34− and SMALD+/CD34+-derived cells. (a) Phase contrast pictures of SMALD+/CD34− and SMALD+/CD34+ cells expanded in proliferation and shifted to differentiation media. SMALD+/CD34− derived cells differentiated into myotubes (phase contrast) expressing fast myosin heavy-chain isoform (b,e; red; nuclei stained in blue). SMALD+/CD34+ derived cells accumulated lipid droplets of various sizes (c,f; droplets stained by Oil Red). Bars = 25 µm (a–e), 8 µm (f). (b) Fluoresence-activated cell sorting phenotypic characterizations for CD56 and CD15 membrane markers on expanded SMALD+/CD34− and SMALD+/CD34+ populations. (c) Quantitative comparisons between populations regarding CD56 or CD15 expression. Most SMALD+/CD34−-derived cells expressed CD56 in culture, but not CD15, whereas half SMALD+/CD34+-derived cells expressed CD15 but never CD56. CD56+ cells also originated from nonsorted and SMALD−/CD34− fractions. n, numbers of biopsies analyzed. SMALD, skeletal muscle aldehyde dehydrogenase. Molecular Therapy 2009 17, 1948-1958DOI: (10.1038/mt.2009.204) Copyright © 2009 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Establishment and use of the predictor percentage (PP). (a) Initial fluoresence-activated cell sorting analysis of Aldefluor and CD34-allophycocyanin labeling on dissociated muscle cells (n = 20 biopsies) enabled calculation of PP value for each biopsy, before expansion in culture. Upon phenotyping (CD56, CD15), cultures were divided in two groups according to respective proportions of markers: [56+ > 15+] and [56+ < 15+]. In each group, biopsies (circles) were ranked as functions of their initial PP, with median PP indicated by black dash. The difference between groups was significant (P < 0.01). At the threshold PP value of 25.5% (dashed line) the outcome of a culture was equivalent regarding the yield in CD56+ and CD15+ cells. (b) Illustration of calculated outcome probabilities at established PP values. Below 25.5%, the probability is higher to produce more CD15+ cells than CD56+ cells. Above 25.5%, the probability is higher to produce more CD56+ cells. Molecular Therapy 2009 17, 1948-1958DOI: (10.1038/mt.2009.204) Copyright © 2009 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Participation of SMALD+/CD34− and SMALD+/CD34+ sorted cells to muscle regeneration in vivo. Numerous SMALD+/CD34− cells were identified at respective injection sites by human nuclei (lamin A/C, red), human mitochondrial COX2 (green) and basal lamina delineation (laminin, blue) on transverse (a–r) sections. In s-u (oblique sections), blue DAPI staining of nuclei was illustrated instead of laminin staining. Only a few SMALD+/CD34+ cells were observed at injection sites (a–c, g–i) as labeled for COX2 (asterisks) and lamin A/C (arrows), and remained in the endomysium. In contrast, SMALD+/CD34− cells participated to muscle formation as illustrated by human mitochondria labeling inside muscle fibers indicative of the fusion between donor cells and recipient fibers or the formation de novo of muscle fibers (d–f, j–u, asterisks). Human nuclei were observed inside fibers (arrowheads) or in the endomysium (arrows). Bars = 50 µm (a–f), 10 µm (g–o, s–u), 20 µm (p–r). SMALD, skeletal muscle aldehyde dehydrogenase. Molecular Therapy 2009 17, 1948-1958DOI: (10.1038/mt.2009.204) Copyright © 2009 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 Localization of SMALD+/CD34− cells upon transplantation. SMALD+/CD34− cells were identified at injection sites by human nuclei (lamin A/C, red), dystrophin (green), and basal lamina (laminin, blue) delineations on transverse sections. Human nuclei were observed inside fibers (asterisks) or in the endomysium (arrows; a–f, j–l). Some fibers were surrounded by laminin, but did not express detectable levels of dystrophin, and may be regenerating fibers (d–f, j–l). A few human nuclei were located below basal lamina of muscle fibers (stained by laminin), but still outside them (delineated by dystrophin), hence in a putative satellite cell position (arrowheads; g–i, m–o). Bars = 15 µm (a–i), 8 µm (j–o). SMALD, skeletal muscle aldehyde dehydrogenase. Molecular Therapy 2009 17, 1948-1958DOI: (10.1038/mt.2009.204) Copyright © 2009 The American Society of Gene & Cell Therapy Terms and Conditions